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The hydromethanolic extract of Sapindus saponaria L. aerial parts was investigated for antimicrobial activity (against several Gram-
positive and Gram-negative bacteria and fungi) and capacity to inhibit the growth of different human tumor cell lines as also
nontumor liver cells. The evaluated extract was further characterized in terms of phytochemicals using UV, 1H-NMR, 13C-NMR,
and MS spectroscopic tools. The extract has shown a significant antimicrobial activity on all tested bacterial and fungal species.
The best activity was achieved against Bacillus cereus and Staphylococcus aureus among bacteria and against all three Penicillium
species tested. It also revealed cytotoxicity against human colon (HCT-15), cervical (HeLa), breast (MCF-7), and lung (NCI-H460)
carcinoma cell lines, with HeLa being the most susceptible tumor cell line. The extract was not toxic for nontumor liver cells.
Chromatographic separation of the extract resulted in the isolation and identification of stigmasterol, oleanolic acid, luteolin,
luteolin 8-𝐶-𝛽-glucoside (orientin), luteolin 6-𝐶-𝛽-glucoside (isoorientin), luteolin 7-𝑂-𝛽-glucuronide, and rutin. The results of
the present findings may be useful for the discovery of novel antitumor and antimicrobial agents from plant origin.
1. Introduction
Plants are considered as one of the main sources of biologi-
cally active compounds. In spite of the recent domination of
the synthetic chemistry as a method to discover and produce
drugs, the potential of bioactive plants or their extracts to
provide new and novel products for disease treatment and
prevention is still enormous [1].
The discovery of antibiotics has decreased the spread and
severity of a wide variety of diseases. However, and as a result
of their uncontrolled use, the efficiency of many antibiotics is
being threatened by the emergence of microbial resistance to
existing chemotherapeutic agents [2].While bioactive natural
compounds have been isolatedmainly from cultivablemicro-
bial strains, untapped biologically active metabolites of dif-
ferent resources including plants remain to be investigated to
alleviate or help responding to current health care situations
[3]. Plant-derived natural products represent an attractive
source of antimicrobial agents since they are natural, have
manageable side effects, and are available at affordable prices
[4]. Furthermore, those natural products may have different
mechanisms from conventional drugs and could be of clinical
importance in health care improvement [5].
Cancer is characterized by uncontrolled growth and
spread of abnormal cells [6]. For many years, scientists
were searching for chemically synthesized compounds with
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antitumor properties. In the last few decades, research has
focused on the use of natural products, crude plant extracts,
or a combination of different phytochemicals for cancer
therapy; this trend is based upon; first, the synergistic effect
of the different plant metabolites in the crude extract and,
second, the multiple points of intervention of such extracts
[7].
Sapindus saponaria L. is a tree from Sapindaceae family
and it is popularly known as soapberry, being distributed in
Central and South America. The bark, root, and fruits are
used in popular medicine as tranquilizer, astringent, diuretic,
expectorant, tonic, blood cleanser, healing and to counter
cough [8], being also a neutralizer of hemorrhage [9]. Its
fruits have activity as antifungal [10] and larvicidal [11].
Abdel-Wahab and Selim [12], detected the presence of car-
bohydrates, steroids, flavonoids, and saponins in leaves and
stems of S. saponaria.
The objective of the present study was to investigate
antimicrobial activity of the hydromethanolic extract of
S. saponaria aerial parts, and also its capacity to inhibit
the growth of different human tumor cell lines. The main
phytochemicals present in the extract were completely char-
acterized by UV, 1H-NMR, 13C-NMR, and MS.
2. Materials and Methods
2.1. Plant Material and Preparation of the Hydromethanolic
Extract. Sapindus saponaria L. aerial parts were collected
fromAl-Zohiriya garden, Giza, Egypt, inApril 2011.The plant
was identified by Dr. Mohammed El-Gebaly, Department
of Botany, National Research Centre (NRC), and by Mrs.
Tereez Labib, Consultant of plant taxonomy at the Ministry
of Agriculture andDirector ofOrman botanical garden, Giza,
Egypt. A voucher specimen number 20532ss was deposited in
the herbarium of Al-Zohiriya garden, Giza, Egypt.
For the extract preparation, 1.2 kg of air dried powder of
S. saponaria aerial parts was extracted with methanol : water
80 : 20 (v/v) at room temperature several times until exhaus-
tion.The extract was concentrated under reduced pressure to
give 68 g of crude extract.
2.2. Evaluation of Antimicrobial Activity of
the Hydromethanolic Extract
Antibacterial Activity. The following Gram (−) (Enterobac-
ter cloacae human isolate, Escherichia coli ATCC 35210,
Pseudomonas aeruginosa ATCC 27853, and Salmonella
typhimurium ATCC 13311) and Gram (+) bacteria (Bacillus
cereus clinical isolate, Listeria monocytogenes NCTC 7973,
Micrococcus flavus ATCC 10240, and Staphylococcus aureus
ATCC 6538) were used. The organisms were obtained from
Mycological Laboratory, Department of Plant Physiology,
Institute for Biological Research “Sinisˇa Stankovic´,” Univer-
sity of Belgrade, Serbia. The antibacterial assay was carried
out by microdilution method [13]. The bacterial suspensions
were adjusted with sterile saline to a concentration of 1.0 ×
105 CFU/mL. The inocula were prepared daily and stored
at 4∘C until use. Dilutions of the inocula were cultured
on solid medium to verify the absence of contamination
and to check the validity of the inoculum. The minimum
inhibitory and bactericidal concentrations (MICs andMBCs)
were determined using 96-well microtitre plates. The extract
was diluted in 5% of DMSO (10mg/mL) and added to tryptic
soy broth (TSB) medium (100 𝜇L) with bacterial inoculum
(1.0× 104 CFUperwell) to achieve thewanted concentrations.
The microplates were incubated at rotary shaker (160 rpm)
for 24 h at 37∘C. The following day, 30 𝜇L of 0.2mg/mL
solution of INT (𝑝-iodonitrotetrazolium violet) was added,
and the plates were returned to the incubator for at least
one-half hour to ensure adequate color reaction. Inhibition
of growth was indicated by a clear solution or a definite
decrease in color reaction [14]. The lowest concentrations
without visible growth (at the binocular microscope) were
defined as concentrations that completely inhibited bacterial
growth (MICs). The MBCs were determined by serial sub-
cultivation of 2𝜇L into microtitre plates containing 100𝜇L of
broth per well and further incubation for 24 h. The lowest
concentration with no visible growth was defined as the
MBC, indicating 99.5% killing of the original inoculum. The
optical density of each well was measured at a wavelength of
655 nm by microplate manager 4.0 (Bio-Rad Laboratories)
and compared with a blank and the positive control. The
antibiotics streptomycin and ampicillin were used as positive
controls (1mg/mL in sterile physiological saline). Three
independent experiments were performed in triplicate.
Antifungal Activity. The used fungi are Aspergillus fumigatus
(ATCC 1022),Aspergillus versicolor (ATCC 11730),Aspergillus
ochraceus (ATCC 12066), Aspergillus niger (ATCC 6275),
Trichoderma viride (IAM 5061), Penicillium funiculosum
(ATCC 36839), Penicillium ochrochloron (ATCC 9112), and
Penicillium verrucosum var. cyclopium were obtained from
Mycological Laboratory, Department of Plant Physiology,
Institute for Biological Research “Sinisˇa Stankovic´,” Univer-
sity of Belgrade, Serbia. The micromycetes were maintained
on malt agar and the cultures were stored at 4∘C and sub-
cultured once a month. The antifungal assay was carried
out by modified microdilution technique [15, 16]. The fungal
spores were washed from the surface of agar plates with
sterile 0.85% saline containing 0.1%Tween 80 (v/v).The spore
suspension was adjusted with sterile saline to a concentration
of approximately 1.0 × 105 in a final volume of 100𝜇L per
well.The inocula were stored at 4∘C for further use. Dilutions
of the inoculum were cultured on solid malt agar to verify
the absence of contamination and to check the validity of
the inoculum. MIC determinations were performed by a
serial dilution technique using 96-well microtiter plates. The
extract was diluted in 5% of DMSO (10mg/mL) and added in
broth Malt Medium (MA) with inoculum. The microplates
were incubated at rotary shaker (160 rpm) for 72 h at 28∘C.
The lowest concentrations without visible growth (at the
binocular microscope) were defined as MICs. The fungicidal
concentrations (MFCs) were determined by serial subculti-
vation of 2𝜇L of tested fractions dissolved in medium and
inoculated for 72 h into microtiter plates containing 100𝜇L of
broth per well and further incubation for 72 h at 28∘C. The
lowest concentration with no visible growth was defined as
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MFC indicating 99.5% killing of the original inoculum. The
fungicides bifonazole and ketoconazole were used as positive
controls (1–3500 𝜇g/mL). Three independent experiments
were performed in duplicate.
2.3. Evaluation of Cells Growth Inhibition Capacity of the
Hydromethanolic Extract. Five human tumor cell lines were
used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer), HCT-15 (colon carcinoma), HeLa
(cervical carcinoma), and HepG2 (hepatocellular carci-
noma). Cells were routinely maintained as adherent cell cul-
tures in RPMI-1640medium containing 10% heat-inactivated
fetal bovine serum (FBS) and 2mM glutamine (MCF-
7, NCI-H460, and HCT-15) or in DMEM supplemented
with 10% FBS, 2mM glutamine, 100U/mL penicillin, and
100mg/mL streptomycin (HeLa and HepG2 cells), at 37∘C,
in a humidified air incubator containing 5% CO
2
. Each cell
line was plated at an appropriate density (7.5 × 103 cells/well
for MCF-7, NCI-H460, and HCT-15 or 1.0 × 104 cells/well
for HeLa and HepG2) in 96-well plates and allowed to be
attached for 24 h. Sulforhodamine B assay was performed
according to a procedure previously described by the authors
[17]. Briefly, cells were then treated for 48 h with various
extract concentrations. Following this incubation period, the
adherent cells were fixed by adding 10% cold trichloroacetic
acid (TCA, 100 𝜇L) and incubated for 60min at 4∘C. Plates
were then washed with deionized water and dried; sulforho-
damine B solution (0.1% in 1% acetic acid, 100𝜇L) was then
added to each plate well and incubated for 30min at room
temperature. Unbound SRB was removed by washing with
1% acetic acid. Plates were air dried, the bound SRB was
solubilised with 10mM Tris (200𝜇L) and the absorbance
was measured at 540 nm in the microplate reader mentioned
above.
For hepatotoxicity evaluation, a cell culture was prepared
from a freshly harvested porcine liver obtained from a local
slaughter house, according to a procedure established by the
authors [17]; it was designed as PLP2. Cultivation of the cells
was continuedwith directmonitoring every two to three days
using a phase contrast microscope. Before confluence was
reached, cells were subcultured and plated in 96-well plates
at a density of 1.0 × 104 cells/well and cultivated in DMEM
medium with 10% FBS, 100U/mL penicillin, and 100 𝜇g/mL
streptomycin. Ellipticine was used as positive control (0.24–
65.2𝜇g/mL).
Three independent experiments were performed in tripli-
cate, and the results were expressed asmean values± standard
deviation (SD).
2.4. Phytochemical Characterization of
the Hydromethanolic Extract
Experimental. UV/VIS: ShimadzuUV-visible recording spec-
trophotometer model-UV 240 (NRC, Egypt). Spectroscopic
data: NMR—Varian, 400MHz. MS (Finnigan MAT SSQ
7000, 70 ev). Silica gel (60–200mesh, Merck), Sephadex LH-
20 (Sigma), thin layer chromatography (TLC): precoated
sheets of silica gel 60 F
254
(Merck).
Isolation of the Bioactive Compounds. The crude hydrometh-
anolic extract (68 g) was defatted with petroleum ether (60–
80∘C); the defatted extract (52 g) was subjected to silica gel
column chromatography elutingwith dichloromethane, ethyl
acetate, and methanol gradually. The fractions that showed
similar thin layer chromatography (TLC) were collected and,
according to that, four fractions were obtained. Fraction 1
(1.7 g) elutedwith dichloromethane : ethyl acetate (80 : 20 v/v)
gave compound (1) (stigmasterol, 19mg) and further elu-
tion with dichloromethane : ethyl acetate (60 : 40 v/v) gave
compound (2) (oleanolic acid, 22mg). Fraction 2 (1.4 g)
eluted with ethyl acetate gave compound (3) (luteolin, 12mg).
Fraction 3 (900mg) eluted with ethyl acetate :methanol
(95 : 5 v/v) gave compound (4) (luteolin 8-𝐶-𝛽-glucoside
(orientin), 24mg) and compound (5) (luteolin 6-𝐶-𝛽-
glucoside (isoorientin), 27mg), and further elutionwith ethyl
acetate and methanol (90 : 10 and 80 : 20 v/v), respectively,
gave compound (6) (luteolin 7-𝑂-𝛽-glucuronide, 29mg) and
compound (7) (quercetin 3-𝑂-𝛼-rutinoside, 22mg) obtained
from fraction 4 (1.75mg). All compounds were purified on
sephadex LH-20 column.
Acid Hydrolysis of Flavonoids. Solutions of 5mg of com-
pounds (4), (5), (6), and (7) in 5mL 10% HCl were heated
for 5 h.The reactionmixture was extracted with ethyl acetate.
The ethyl acetate fraction (aglycone) and the aqueous fraction
(sugars) were concentrated for identification. The sugars
were identified by TLC (acetonitrile : water 85 : 15 v/v) by
comparison with authentic standards.
3. Results and Discussion
3.1. Antimicrobial Activity. Theresults of antibacterial activity
of hydromethanolic extract of S. saponaria are presented
in Table 1 and Figure 1. Inhibitory activity was achieved at
concentration of 0.3–1.25mg/mL, while bactericidal effect
was obtained at 1.25–2.5mg/mL. The most sensitive bacte-
rial species were Bacillus cereus and Staphylococcus aureus,
while Listeria monocytogenes and Salmonella typhimurium
were the most resistant species to tested extract. In gen-
eral, both antibiotics showed better activity than the tested
extract. Streptomycin possessed MICs of 0.05–0.25mg/mL
and MBCs of 0.10–0.50mg/mL, while ampicillin revealed
MICs of 0.10–0.30mg/mL and MBCs of 0.15–0.50mg/mL.
All microfungi were sensitive to hydromethanolic extract
of S. saponaria (Table 2 and Figure 2). The extract inhibited
all microfungi at 0.075–0.6mg/mL (MIC) and completely
stopped the growth (MFC) at 0.3–1.25mg/mL. The extract
exhibited inhibitory concentrations at 0.075–0.3mg/mL and
fungicidal effects at 0.3–5.0mg/mL. The most sensitive
microfungi were Penicillium species; on the other hand,
Aspergillus fumigatus was the most resistant to the tested
extract. Commercial antifungal agents, bifonazole (MIC
0.10–0.20mg/mL; MFC 0.20–0.25mg/mL) and ketoconazole
(MIC 0.15–2.50mg/mL; MFC 0.20–3.50mg/mL), were in
general more active than the investigated extract, with an
exception in case of Penicillium species. The extract showed
higher inhibitory activity effect towards all three Penicillium
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Table 1: Antibacterial activity of the hydromethanolic extract of Sapindus saponaria aerial parts and standards.
Bacteria
Extract
MIC (mg/mL)
MBC (mg/mL)
Streptomycin
MIC (mg/mL)
MBC (mg/mL)
Ampicillin
MIC (mg/mL)
MBC (mg/mL)
Bacillus cereus 0.3 ± 0.00 0.05 ± 0.005 0.1 ± 0.05
1.25 ± 0.10 0.1 ± 0.03 0.15 ± 0.05
Micrococcus flavus 0.3 ± 0.01 0.125 ± 0.015 0.1 ± 0.00
2.5 ± 0.30 0.25 ± 0.003 0.15 ± 0.06
Staphylococcus aureus 0.3 ± 0.01 0.25 ± 0.003 0.1 ± 0.05
1.25 ± 0.25 0.50 ± 0.00 0.15 ± 0.00
Listeria monocytogenes 1.25 ± 0.10 0.15 ± 0.05 0.15 ± 0.03
2.5 ± 0.30 0.30 ± 0.03 0.30 ± 0.01
Escherichia coli 0.6 ± 0.00 0.10 ± 0.03 0.30 ± 0.05
1.25 ± 0.10 0.50 ± 0.06 0.50 ± 0.06
Pseudomonas aeruginosa 0.6 ± 0.06 0.05 ± 0.006 0.10 ± 0.00
1.25 ± 0.25 0.10 ± 0.0 0.20 ± 0.05
Enterobacter cloacae 0.6 ± 0.00 0.05 ± 0.005 0.15 ± 0.00
1.25 ± 0.10 0.10 ± 0.06 0.20 ± 0.06
Salmonella typhimurium 1.25 ± 0.25 0.05 ± 0.006 0.15 ± 0.03
2.5 ± 0.00 0.10 ± 0.03 0.20 ± 0.00
MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.
species tested than both mycotics. Also, the tested extract
exhibited higher fungicidal activity against P. ochrochloron
and P. verrucosum than ketoconazole.
According to the existing literature, the investigation of
Sapindus saponaria extracts is limited, but there is more
information about isolated compounds. Extracts from the
dried pericarp of S. saponaria fruits were investigated for
their antifungal activity against clinical isolates of yeasts
Candida albicans and 𝐶. non-albicans from vaginal secre-
tions of women with vulvovaginal candidiasis. From all
tested extracts the n-BuOH and one of its fractions showed
strong activity against all Candida isolates tested [10]. The
acetylated saponin 3-b-O-[a-L-rhamnopyranosyl-(1-3)-b-D-
glucopyranosyl] hederagenin was detected by Lemos et al.
[18] who observed antimicrobial activity against Pseu-
domonas aeruginosa, Bacillus subtilis, and Cryptococcus neo-
formans. Triterpenoid saponins, with hederagenin or oleano-
lic acid as aglycone, have been found to possess antifungal
activity against C. glabrata, C. albicans, Trichosporon beigelii,
Penicillium avelaneum UC-4376, Pyricularia oryzae, Crypto-
coccus neoformans, Coccidioides immitis, and Saccharomyces
cerevisiae as well as against the dermatophytes Microsporum
canis and Trichophyton mentagrophytes [19, 20]. Triterpene
acids (ursolic and oleanolic) isolated from Miconia species
showed a significant antibacterial activity against some bac-
terial strains [21]. Luteolin showed selectively antibacterial
activity against MRSA and methicillin-sensitive S. aureus
strains with MIC, 3.9 to 15.6 and 62.5 to 125𝜇g/mL, respec-
tively [22]. Also luteolin 7-𝑂-glucosides possess antibacterial
activity [23], and rutin has been shown to exhibit antimicro-
bial activity [24].
Fromprevious results it could be noticed that all flavonoid
aglycones (myricetin, quercetin, and luteolin) showed better
antibacterial and antifungal activities than other flavonoid
glycosides [25, 26]. Luteolin exhibited relatively higher activi-
ties than the other compounds andwasmore effective against
fungi than against bacteria [27, 28]. These authors presented
that certain features relating to flavonoid structure and
antimicrobial activity can be identified.The active flavonoids
were polyhydroxylated (myricetin, datiscetin, quercetin, lute-
olin, and kaempferol), except for flavone which does not
contain any hydroxyl group. These active flavonoids have
in common the obligatory C-4 keto group and hydroxyl
group substitutions at C-3, C-5, and C-7 and have at least
one hydroxyl group on ring B. These observations indicate
that the more hydrophilic flavonols or flavones are better
inhibitors than less hydrophilic ones. These observations
suggest that the hydroxyl group at C-3 is required for activity.
This requirement, however, is not necessary for the flavone
skeleton, as in the case of luteolin. Antimicrobial activity of
total extract (although low compared to others) may be due
to the presence of some aglycones, unstable flavonoid gly-
cosides, or some other bioactive secondary metabolites. This
is in agreementwith the literature that plant extracts generally
contain flavonoids in glycosidic form.This may be the reason
why the plant extract did not produce asmarked inhibition as
some fractionated extracts or asmany of the pure compounds
[29].
3.2. Growth Inhibition of Human Tumor Cell Lines. The
hydromethanolic extract of S. saponaria revealed cytotoxicity
against human colon, cervical, breast, and lung carcinoma
cell lines (Table 3). Among the tested human tumor cell
lines, themost susceptible onewasHeLa (cervical carcinoma;
GI
50
= 258𝜇g/mL), showing similar results to the other
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Figure 1: Chemical structure of the compounds isolated and identified in the hydromethanolic extract of Sapindus saponaria aerial parts.
tested tumor cell lines. The extract up to 800 𝜇g/mL did
not show capacity to inhibit the growth of HepG2 cell line
(hepatocellular carcinoma). Moreover, the hydromethanolic
extract of S. saponaria, up to 800𝜇g/mL, was not toxic for
nontumor liver cells. Ellipticine was used as positive control,
but the comparisonwith the extract results should be avoided
because it is an individual/purified compound and not amix-
ture like the extract (in the crude extract the concentration
of each individual bioactive compound is certainly much
lower and in the range of the pure compound). Furthermore,
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Table 2: Antifungal activity of the hydromethanolic extract of Sapindus saponaria aerial parts and standards.
Fungi
Extract
MIC (mg/mL)
MFC (mg/mL)
Bifonazole
MIC (mg/mL)
MFC (mg/mL)
Ketoconazole
MIC (mg/mL)
MFC (mg/mL)
Aspergillus fumigatus 0.6 ± 0.06 0.15 ± 0.03 0.20 ± 0.03
5.0 ± 0.60 0.20 ± 0.06 0.50 ± 0.05
Aspergillus versicolor 0.3 ± 0.06 0.10 ± 0.05 0.20 ± 0.03
0.6 ± 0.06 0.20 ± 0.03 0.50 ± 0.05
Aspergillus ochraceus 0.2 ± 0.03 0.15 ± 0.03 0.15 ± 0.03
0.6 ± 0.00 0.20 ± 0.06 0.20 ± 0.06
Aspergillus niger 0.2 ± 0.03 0.15 ± 0.03 0.20 ± 0.06
0.6 ± 0.06 0.20 ± 0.03 0.50 ± 0.05
Penicillium verucosum
var. cyclopium
0.075 ± 0.00 0.15 ± 0.05 1.0 ± 0.3
0.3 ± 0.03 0.20 ± 0.03 1.0 ± 0.3
Penicillium ochrochloron 0.075 ± 0.00 0.20 ± 0.06 0.20 ± 0.03
0.3 ± 0.03 0.25 ± 0.05 0.50 ± 0.06
Penicillium funiculosum 0.075 ± 0.00 0.20 ± 0.03 2.5 ± 0.3
0.3 ± 0.03 0.25 ± 0.05 3.5 ± 0.5
Trichoderma viride 0.3 ± 0.06 0.10 ± 0.05 0.20 ± 0.03
0.6 ± 0.00 0.20 ± 0.06 0.30 ± 0.06
MIC: minimum inhibitory concentration; MFC: minimum fungicidal concentration.
Figure 2: Antibacterial activity of the hydromethanolic extract of
Sapindus saponaria aerial parts by microdilution method. The rows
represent different bacterial species and columns different extract
concentrations (0.3–2.5mg/mL). Comparison between control-
bacterial growth (K-red color), blank control (B-yellow), and treated
samples (yellow color MIC and MBC) and treated samples with no
activity (red color) in INT assay.
besides ellipticine showing very lowGI
50
values for tumor cell
lines, it also presents high toxicity for normal cells (nontumor
cells).
There is no valuable data about previous investigation of
this plant extracts. Some of the compounds isolated from
this extract were already tested for some biological activity.
Flavonoids are generally regarded to have a wide range
of pharmacological activity (antioxidant, anti-inflammatory,
antimicrobial, antiviral, and antitumor); among these com-
pounds, apigenin and luteolin have been confirmed to have
antitumor activity [22]. Stigmasterol, a constituent isolated
from Bacopa monnieri Linn aerial parts, showed therapeutic
efficacy against Ehrlich ascites carcinoma in mice [30].
Oleanolic acid is a pentacyclic triterpenoidwidely distributed
in nature and possessing various important bioactivities, such
as antitumor and hepatoprotection [31].
The findings revealed that the antimicrobial and antitu-
mor properties of the hydromethanolic extract of S. saponaria
provide preliminary scientific validation for the traditional
medicinal use of this plant as a potential phytotherapeutic
agent in certain diseases and for the control of bacteria
and fungi in the environment. However, the extracts and
active compound isolated from S. saponaria should be further
studied in animal models in order to evaluate their in vitro
efficacy and toxicity.
3.3. Phytochemical Characterization. Chromatographic sep-
aration and purification of the hydromethanolic extract of
S. saponaria aerial parts allowed the identification of seven
bioactive compounds: stigmasterol, oleanolic acid, luteolin,
luteolin 8-𝐶-𝛽-glucoside (orientin), luteolin 6-𝐶-𝛽-glucoside
(isoorientin), luteolin 7-𝑂-𝛽-glucuronide, and rutin (Fig-
ure 3). Their structures were elucidated on the basis of UV,
1H-NMR, 13C-NMR, and MS analyses.
Compound (1) was identified as stigmasterol: white nee-
dle crystals, 1H-NMR (400MHz, CDCl
3
): 𝛿 5.32 (IH, m, H-
6), 5.11 (1H, dd, 𝐽 = 14.2, 8.2Hz, H-22), 5.04 (1H, dd, 𝐽 = 14.2,
8.2Hz, H-23), 3.54 (IH, m, H-3), 1.04 (3H, s, CH
3
-10), 0.9
(3H, d, 𝐽 = 6.5, CH
3
-20), 0.84 (3H, d, 𝐽 = 7.4, CH
3
-27), 0.82
(3H, d, 𝐽 = 7.4, CH
3
-26), 0.68 (3H, s, CH
3
-13). 13C-NMR
(100MHz, CDCl
3
): 𝛿 140.6 (C-5), 138.4 (C-22), 129.1 (C-23),
121.8 (C-6), 71.9 (C-3), 56.7 (C-17), 56.9 (C-14), 50.9 (C-9),
50.7 (C-24), 42.6 (C-13, 4), 39.6 (C-12), 37.4 (C-1), 40.2 (C-
20), 36.7 (C-10), 31.4 (C-8, 7), 31.7 (C-2), 30.9 (C-25), 28.8 (C-
16), 24.8 (C-15), 24.7 (C-28), 21.5 (C-11), 20.8 (C-26), 20.4 (C-
19), 19.7 (C-27), 19.1 (C-21). It gave dark spot under short UV
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Table 3: Cytotoxicity of hydromethanolic extract of Sapindus saponaria aerial parts and ellipticine (standard) in human tumor cell lines and
in nontumor liver primary culture.
Extract (GI50, 𝜇g/mL) Ellipticine (GI50, 𝜇g/mL)
HCT-15 (colon carcinoma) 362.76 ± 14.64 1.91 ± 0.06
HepG2 (hepatocellular carcinoma) >800 3.22 ± 0.67
HeLa (cervical carcinoma) 258.58 ± 3.40 1.14 ± 0.21
MCF-7 (breast carcinoma) 376.34 ± 19.66 0.91 ± 0.04
NCI-H460 (lung carcinoma) 368.29 ± 18.94 1.42 ± 0.00
PLP2 (nontumor liver cells) >800 2.06 ± 0.03
GI50 values correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2.
Figure 3: Antifungal activity of the hydromethanolic extract of
Sapindus saponaria aerial parts by microdilution method. The rows
represent different fungal species and columns different extract
concentrations (0.075–5.0mg/mL). Comparison between control
(K-fungal growth), blank control (B), and treated samples (MIC and
MFC, wells with no fungal growth) and treated samples with no
activity.
light that changed to violet colour on spraying with vanillin
sulphuric and heating in an oven at 110∘C for 5min. NMR
spectral data has shown signals very close to that reported by
Yinusa et al. [32] for stigmasterol.
Compound (2) was identified as oleanolic acid: white
amorphous powder. 1H-NMR (CDCl
3
, 400MHz): 𝛿 5.23 (IH,
t, 𝐽 = 3.4, H-12), 3.17 (1H, dd, 𝐽 = 10, 4.2Hz, H-3), 2.74 (1H,
dd, 𝐽 = 12.5, 4 Hz, H-18), 0.95 (3H, s,Me-23), 0.76 (3H, s,Me-
24), 0.85 (3H, s, Me-25), 0.77 (3H, s, Me-26), 1.23 (3H, s, Me-
27), 0.89 (3H, s,Me-29), 0.95 (3H, s,Me-30). (+) ESI-MS:𝑚/𝑧
456 [M–H]+.This compoundwasmonitored by TLC andwas
detected by heating the plate at 110∘C after spraying with 𝑝-
anisaldehyde-sulfuric acid; furthermore, spectral results were
in agreement with the published data [33].
Compound (3) was identified as luteolin: pale yellow
crystals: UV: 𝜆max (nm) (MeOH): 254, 350, (NaOMe): 273,
411, (AlCl
3
): 272, 330, 343, 421, (AlCl
3
+ HCl): 258, 277, 386,
(NaOAc): 266, 296, 367 (NaOAc+H
3
BO
3
): 260, 306, 370. 1H-
NMR: 𝛿 12.9 (s, 1H, 5-OH), 7.36 (d, 𝐽 = 7.9Hz, 1H, H-6󸀠), 7.34
(d, 𝐽 = 2Hz, 1H, H-2󸀠), 6.82 (d, 𝐽 = 8Hz, 1H, H-5󸀠), 6.64
(s, 1H, H-3), 6.42 (d, 𝐽 = 2Hz, 1H, H-8), 6.17 (d, 𝐽 = 2Hz,
1H, H-6). EI-MS: 𝑚/𝑧 286. This compound was isolated as
a deep purple spot and with spraying with AlCl
3
, it gave a
yellow fluorescence color under UV light; UV spectral data
confirm that it is a flavone with free OH groups at positions
3󸀠, 4󸀠 (ring B) and 5, 7 (ring A); 1H-NMR and MS are very
similar to the characteristics of luteolin reported by Saeidnia
et al. [34].
Compound (4) was identified as luteolin 8-𝐶-𝛽-glucoside
(orientin): yellow crystals. UV: 𝜆max (nm) (MeOH): 252,
266, 348, (NaOMe): 268, 403, (AlCl
3
): 272, 302, 332,
422, (AlCl
3
/HCl): 268, 302, 357, 384, (NaOAc): 267, 355,
(NaOAc/H
3
BO
3
): 262, 371. 1H NMR (DMSO-d6, 400MHz):
𝛿 ppm 7.52 (1H, dd, 𝐽 = 2, 8.2Hz, H-6󸀠), 7.45 (1H, d, 𝐽 = 2Hz,
H-2󸀠), 6.84 (1H, d, 𝐽 = 8.2Hz, H-5󸀠), 6.65 (1H, s, H-3), 6.22
(1H, s, H-6), 4.64 (1H, d, 𝐽 = 9.5Hz, H-1󸀠󸀠), 3.2–4.1 (the rest
of sugar protons). 13CNMRspectrum (DMSO-d6, 100MHz):
𝛿 ppm 181.65 (C-4), 166.95 (C-2), 163.85 (C-7), 160.34 (C-5),
156.25 (C-9), 151.2 (C-4󸀠), 146.45 (C-3󸀠), 121.98 (C-1󸀠), 119.25
(C-6󸀠), 115.78 (C-5󸀠), 113.47 (C-2󸀠), 104.58 (C-8), 103.18 (C-10),
101.85 (C-3), 98.54 (C-6), 81.86 (C-5󸀠󸀠), 78.75 (C-2󸀠󸀠), 73.62 (C-
1󸀠󸀠), 70.84 (C-3󸀠󸀠), 70.65 (C-4󸀠󸀠), 61.64 (C-6󸀠󸀠).
Compound (5) was identified as luteolin 6-𝐶-𝛽-glucoside
(isoorientin): yellow crystals. UV: 𝜆max (nm) (MeOH): 245,
267, 345 (NaOMe): 225, 264, 406, (AlCl
3
): 225, 262, 365,
(AlCl
3
/HCl): 263, 282, 296, 358, 365, (NaOAc): 258, 268, 294,
340, 354 (NaOAc/H
3
BO
3
): 271, 307, 352. 1H NMR (DMSO-
d6, 270MHz): 𝛿 ppm 7.45 (1H, dd, 𝐽 = 2.5, 8.2Hz, H-6󸀠),
7.4 (1H, d, 𝐽 = 2.5Hz, H-2󸀠), 6.9 (1H, d, 𝐽 = 8.2Hz, H-5󸀠),
6.64 (1H, s, H-3), 6.47 (1H, s, H-8), 4.62 (1H, d, 𝐽 = 9.5Hz,
H-1󸀠󸀠), 3.1–4.06 ppm (the rest of sugar protons). 13C NMR
(DMSO-d6, 100MHz): 𝛿 ppm 182.45 (C-4), 164.74 (C-7),
164.35 (C-2), 161.62 (C-9), 156.98 (C-5), 150.55 (C-4󸀠), 146.64
(C-3󸀠), 122.18 (C-1󸀠), 119.65 (C-6󸀠), 116.82 (C-5󸀠), 113.94 (C-2󸀠),
109.56 (C-6), 104.25 (C-10), 103.48 (C-3), 94.35 (C-8), 82.15
(C-5󸀠󸀠), 79.85 (C-2󸀠󸀠), 73.75 (C-1󸀠󸀠), 71.48 (C-3󸀠󸀠), 70.94 (C-4󸀠󸀠),
62.35 (C-6󸀠󸀠). Compounds (4) and (5) showed deep purple
spots under UV light which changed to yellowwith ammonia
vapor indicating that they are flavones with free 5-OH and
4󸀠-OH [35]. Complete acid hydrolysis of the two compounds
revealed that no sugars were detected meaning that they
remained without change in addition to the appearance of
an additional spot on the chromatogram (Wessely-Moser
rearrangement between C-6 and C-8), which may be due
to acid isomerization [36], indicating that the compounds
aremono-C-glycosides.Thus, the compounds were subjected
to ferric chloride degradation and cochromatographed with
authentic sugars samples, where glucose was detected. UV
spectral data and NMR signals for the two compounds are
very similar to the ones reported for orientin and isoorientin,
respectively [37, 38].
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Compound (6) was identified as luteolin 7-𝑂-𝛽-
glucuronide: 1H-NMR (400MHz, DMSO-𝑑
6
): 𝛿 ppm 12.92
(1H, s, 5-OH), 7.45 (1H d, 𝐽 = 2.0Hz, H-2󸀠), 7.38 (1H, dd,
𝐽 = 8.4Hz, 𝐽 = 2.0Hz, H-6󸀠), 6.82 (1H, d, 𝐽 = 8.4Hz, H-5󸀠),
6.78 (1H, d, 𝐽 = 1.9Hz, H-8), 6.72 (1H, s, H-3), 6.37 (1H, d,
𝐽 = 1.9Hz, H-6,), 5.12 (1H, d, 𝐽 = 7.5Hz, H-1󸀠󸀠), 3.2–4.1 ppm
(rest of sugar protons). 13CNMR (100MHz, DMSO-𝑑
6
): d
182.7 (C-4), 172.54 (C-6󸀠󸀠), 165.17 (C-2), 163.68 (C-7), 161.75
(C-5), 157.62 (C-9), 150.86 (C-4󸀠), 146.63 (C-3󸀠), 121.77 (C-1󸀠),
119.78 (C-6󸀠), 116.71 (C-5󸀠), 114.19 (C-2󸀠), 105.95 (C-10), 103.62
(C-3), 100.25 (C-6, C-1󸀠󸀠), 95.24 (C-8), 77.18 (C-3󸀠󸀠), 74.55
(C-5󸀠󸀠), 73.63 (C-2󸀠󸀠), 72.65 (C-4󸀠󸀠). (−) ESIMS: 𝑚/𝑧 461
[M–H]−.
Compound (7) was identified as quercetin 3-𝑂-
rutinoside (rutin): 1H-NMR (DMSO, 270MHz): 𝛿 12.75 (s,
1H, 5-OH), 7.58 (2H, m, 𝐽 = 8Hz, H-2󸀠, 6󸀠), 6.84 (d, 1H,
𝐽 = 8.5Hz, H-5󸀠), 6.37 (1H, d, 𝐽 = 2.2Hz, H-8), 6.19 (1H, d,
𝐽 = 2.2Hz, H-6), 5.25 (1H, d, 𝐽 = 7.5Hz, H-1󸀠󸀠), 4.48 (1H, d,
𝐽 = 2.2Hz, H-1󸀠󸀠󸀠), 1.15 (d, 𝐽 = 6Hz, CH
3
-rhamnosyl). 13C
NMR (CD
3
OD, 100MHz): quercetin: 𝛿 179.28 (C-4), 166.0
(C-7), 162.48 (C-5), 159.26 (C-9), 158.48 (C-2), 149.84 (C-4󸀠),
145.76 (C-3󸀠), 135.58 (C-3), 123.42 (C-6󸀠), 123.22 (C-1󸀠),
117.58 (C-2󸀠), 116.26 (C-5󸀠), 105.57 (C-10), 98.74 (C-6), 94.92
(C-8), glucose sugar: 𝛿 104.85 (C-1󸀠󸀠󸀠), 78.15 (C-5󸀠󸀠), 77.35
(C-3󸀠󸀠), 75.64 (C-2󸀠󸀠󸀠󸀠), 71.73 (C-4󸀠󸀠), 68.64 (C-6󸀠󸀠), rhamnose
sugar: 𝛿 102.53 (C-1󸀠󸀠󸀠), 73.85 (C-4󸀠󸀠󸀠), 72.65 (C-2󸀠󸀠󸀠), 72.35
(C-3󸀠󸀠󸀠), 69.4 (C-5󸀠󸀠󸀠), 17.65 (C-6󸀠󸀠󸀠). (−) ESIMS: 𝑚/𝑧 609
[M–H]−. Compounds (6) and (7) showed deep purple spots
under UV light and after spraying with AlCl
3
gave a yellow
flurorescent color. EI-MS data and 1H- and 13C-NMR data
were in agreement with the results reported in the literature
for luteolin 7-𝑂-𝛽-glucuronide [39] and rutin [40].
4. Conclusion
The extract has shown a significant antimicrobial activity
towards all bacterial and fungal species tested. It can be
concluded that tested extract showed strong antibacterial
and antifungal effect against human and animal pathogenic
species, food spoilage and contaminators, and mycotoxin
producers. It also revealed some cytotoxicity against human
colon (HCT-15), cervical (HeLa), breast (MCF-7), and lung
(NCI-H460) carcinoma cell lines, with HeLa being the most
susceptible tumor cell line. The extract was not toxic for
nontumor liver cells. Chromatographic separation of the
extract resulted in the isolation of stigmasterol, oleanolic
acid, luteolin, luteolin 8-𝐶-𝛽-glucoside (orientin), luteolin
6-𝐶-𝛽-glucoside (isoorientin), luteolin 7-𝑂-𝛽-glucuronide,
and rutin. The compounds were identified by UV, 1H-NMR,
13C-NMR, and MS spectroscopic tools. The results reported
hereinmay be useful for the discovery of novel anticancer and
antimicrobial agents from plant origin.
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